L. Nicolas Gonzalez Castro, Md, Phd

This study tests a combination of three drugs (pembrolizumab, olaparib, and temozolomide) in people whose glioblastoma brain tumor has come back after prior treatment. The goal is to see if this mix can shrink the tumor or slow its growth by boosting the immune system and damagin…